Hi James, I checked and did not see any email from you, so I will not share all of my ideas in a public forum. What I will discuss here is some safe natural products that can possibly help to slow the progress while the clock ticks.
I believe I saw you mention that your wife tried resveratrol. While I do not expect any miraculous results from that, it could still buy some time due to its ER and mitochondrial protection characteristics at a much lower level than 2-73 but not to be ignored either and has no safety issues at typical dose even for geriatrics. Along with this, PQQ is good and include vitamin E.
Something else I would recommend is Magnesium Threonate, too long to get into here but very safe and biochemically makes sense that it could lend some assistance in terms of it lowering calcium influx and do not underestimate this. Look this up! Very safe. Berberine is a sigma-1 agonist and I would suggest before bedtime every other day. Huperzine-A may be synergistic with the extended release Namenda she is taking. This is available in health stores and often combined with Ginkgo Biloba which can help cerebral micro circulation. Selegiline is available from overseas and is being revisited in combination with other meds. WarddeanmdDOTcom/deprenyl-Alzheimers-disese-update
I believe Anavex 2-73 is a revolutionary breakthrough, however unfortunately will still take time before coming to market.
They have a CRO contract lab synthesize it for them. It was recently available for research purposes but I see now they have tightened up its availability. The further protection of the IP here is a very good sign of what is to come.
He usually does a nice point by point summary. Hopefully some people ask questions that JNap didn't ask, so we get a nice balance of news. Looking forward to hearing from anyone who goes.
James and David, so sorry to hear about your situations. Yes, get this available fast! But in the meanwhile, email me and tell me what if anything they're currently taking. James, I've seen your posts before. What is your wife currently taking?
The company is in a MUCH better position now than it was a year ago by all accounts. The stock is absurdly under-valued and we are in the pivotal trial with better than 50% conversions!
Numbers and extent of TBI is relevant only to this study. Actual commercial usage of the NSS will not be so constrained. If a doc is going to do screws and rods he will take the extra 15 minutes and do the NSS.
Your trolling here is beyond tiresome. You need to find another YMB to act the fool on. Not only are there no paid pumped here, there aren't even any unpaid pumpers. Nobody cares about your nonsense posts day in and day out.
Give us a break newbie. There are more bashers here than anything else and I haven't seen a bona fide pumper here in a dog's age. Please find another stock board to play troll on. We have enough here already.
Baseless and faulty logic and erroneous extrapolation of the pace of a study.
Sentiment: Strong Buy
I agree, all important questions that beg for answers. Sad to say but from one year ago until today, my impression of the CEO has dropped considerably, along with unfortunately the market value of the stock. In the OTC days a stable low end baseline was somewhere around $2.25 and would go a bit lower on scarcity of news and higher (above $3) on news and developments. That stable baseline is $9.00 today. It is senseless that we cannot even attain the nine-handle! I actually believe this stock would be trading more robustly if it was back around $12.
Sorry it is slide 15 but viewing it on an iPhone so I thought the numbers were at the top. InVivo probably did some additional porcine work with the scaffold plus Schwann cells. Looks promising. The next generation of NSS will be even more effective than it already is by itself. That could be the version that they take the PMA-ERP path with for the remainder of acute SCI.
Slide 14: Curious as to when they did this work including the Schwann cells and why it wasn't discussed in a press release?
That must have been George Postupak using his boilerplate commentary about "the science" that he has used over and over again on multiple stock boards. Lately he is spoofing many longs' aliases while writing his juvenile nonsense? It's hard to believe he is supposed to be a mature adult, so you know he has some mental issues. When I see someone devote their entire free time bashing stocks and shorting them (all while gainfully unemployed unless a paid basher), all I can think is, LOSER!
Attila, remember pre split when sometimes we'd move up 30 or 40 cents without any real news? That's like $1.20 to $1.30 now. Think about that for a moment, considering how the price of the recent cheap/underpriced cash raise should have at least defined a bottom. So yes, like you I welcome this movement without news. I consider it to be a "positive correction" and we have another $1.20 more to go just to get back to a legitimate bottom. That bottom is still too low and considering we are near a significant inflection catalyst (5 AIS conversions), still another 50 cents pre split or $2.00 undervalued prior to actually getting some significant news.
Significant news, i.e. Reaching and exceeding the OPC minimum, ROW sites, acceleration of enrollments, FDA pre-IND meeting, resolutions from such meeting like fast track on Neural Trails, etc., should, IMO, very legitimately put us back into the mid teens again.
Sentiment: Strong Buy